NCT03572426View on ClinicalTrials.gov

Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

June 13, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions
Bipolar Disorder
Interventions
OTHER

genotyping all subjects

genotyping using SNaPshot genotyping method.

Trial Locations (1)

80045

Helen and Arthur E Johnson Depression Center, Aurora

All Listed Sponsors
collaborator

Sigma Theta Tau

UNKNOWN

lead

University of Colorado, Denver

OTHER

NCT03572426 - Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder | Biotech Hunter | Biotech Hunter